Publications by authors named "Isaura Fernandez"

Claim this Profile
N
Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast Cancer.
Miguel Martín, Angel L Guerrero-Zotano, María E Pérez-López, Manuel Ruiz-Borrego, Noelia Martinez Jañez, Isaura Fernandez

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of risk prediction scores including all types of cancer-associated thrombosis.
Irene González Caraballo, Bárbara Lobato Delgado, Magdalena Ruiz Zamorano, Mercedes Salgado, Vanessa Pachón

Clin Transl Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Juan F Cueva, Isabel Palacio, Cristina Churruca, Ana Herrero, Beatriz Pardo

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life with palbociclib plus fulvestrant placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ariadna Tibau, M Teresa Martínez, Manuel Ramos, Luis De La Cruz-Merino, Ana Santaballa

Ther Adv Med Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM-GECOD clinical guideline for unknown primary cancer (2021).
Ferrán Losa, Isaura Fernández, Olatz Etxaniz, Alejandra Giménez, Paula Gomila

Clin Transl Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
Ana Lluch, Carlos H Barrios, Laura Torrecillas, Manuel Ruiz-Borrego, Jose Bines

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
Carmen Balana, Ramon De Las Penas, Juan Manuel Sepúlveda, Miguel J Gil-Gil, Raquel Luque, Isaura Fernandez

J Neurooncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.
Noelia Martínez-Jañez, Ignacio Chacón, Ana de Juan, Luis Cruz-Merino, Sònia Del Barco

Breast Care (Basel)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis